European regulators Struggle with Globalisation of Clinical Trials - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

European regulators Struggle with Globalisation of Clinical Trials
The globalisation of clinical trials is putting pressure on the European Medicines Agency.


Pharmaceutical Technology Europe
Volume 24, Issue 6

8. I. Hall, "Pharma firms hit back at C4's drugs documentary" (PR Week, 2003). http://www.prweek.com/, accessed 30 April 2012.

9. N. Lakhani "From tragedy to travesty: Drugs tested on survivors of Bhopal" (The Independent, 2011). http://www.independent.co.uk/, accessed 30 April 2012.

10. A. Buncome, "Delhi to examine weak regulation' of clinical trials" (The Independent, 2011). http://www.independent.co.uk/, accessed 30 April 2012.

11. N. Lakhani, "Europe targets drug firms over unethical practices" (The Independent, 2011). http://www.independent.co.uk/. accessed 30 April 2012.

12 Wemos, "The Globalization of Clinical Trials: Testimonies from Human Subjects" (Wemos website, 2010). http://www.wemos.nl/, accessed 30 April 2012.

13 EMA, "Towards a robust global framework for conduct and oversight of clinical trials" (EMA website, 2012). http://www.ema.europa.eu/, accessed 30 April 2012.

14. EMA, "International collaboration on good manufacturing practice inspections expanded" (EMA website, 2012). http://www.ema.europa.eu/, accessed 30 April 2012.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Source: Pharmaceutical Technology Europe,
Click here